Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer

Tumor Biology

Volumn 33, Issue 3, 2012, Pages 731-738

  Kim, Jin Ju ^a   Kim, Jong Tae ^a   Yoon, Hyo Ran ^a   Kang, Min Ah ^a   Kim, Joo Heon ^b   Lee, Young Ha ^c   Kim, Jae Wha ^a   Lee, Seon Jin ^a   Song, Eun Young ^a   Myung, Pyung Keun ^d   Lee, Hee Gu ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Eulji University School of Medicine   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

Gastric cancer; Immunohistochemistry; Invasiveness; Kallikrein; KLK6

Indexed keywords

KALLIKREIN 6; SMALL INTERFERING RNA; TUMOR MARKER; UVOMORULIN; CADHERIN; KALLIKREIN; KLK6 PROTEIN, HUMAN; MESSENGER RNA;

ARTICLE; CANCER STAGING; CELL INVASION; CONTROLLED STUDY; DISEASE MARKER; ENZYME BLOOD LEVEL; ENZYME RELEASE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KLK6 GENE; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CANCER; UPREGULATION; CANCER INVASION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SECRETION; STOMACH TUMOR; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

CADHERINS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84863585880     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0267-1     Document Type: Article

References (31)

1. Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev. 2001;22:184-204.
2. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Oesterling JE. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology. 1995;45:729-44.
3. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Human kallikrein 2 (hk2) and prostate-specific antigen (psa): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci. 1998;35:275-368.
4. Stenman UH. New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hk2) as a marker for prostatic disease. Clin Chem. 1999;45:753-4.
5. Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004;4:876-90.
6. Diamandis EP, Yousef GM, Soosaipillai AR, Grass L, Porter A, Little S, Sotiropoulou G. Immunofluorometric assay of human kallikrein 6 (zyme/protease m/neurosin) and preliminary clinical applications. Clin Biochem. 2000;33:369-75.
7. Gan L, Lee I, Smith R, Argonza-Barrett R, Lei H, McCuaig J, Moss P, Paeper B, Wang K. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene. 2000;257:119-30.
8. Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med. 1996;2:624-36.
9. Little SP, Dixon EP, Norris F, Buckley W, Becker GW, Johnson M, Dobbins JR, Wyrick T, Miller JR, MacKellar W, Hepburn D, Corvalan J, McClure D, Liu X, Stephenson D, Clemens J, Johnstone EM. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J Biol Chem. 1997;272:25135-42.
10. Yamashiro K, Tsuruoka N, Kodama S, Tsujimoto M, Yamamura Y, Tanaka T, Nakazato H, Yamaguchi N. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim Biophys Acta. 1997;1350:11-4.
11. Ghosh MC, Grass L, Soosaipillai A, Sotiropoulou G, Diamandis EP. Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 2004;25:193-9.
12. Paliouras M, Borgono C, Diamandis EP. Human tissue kallikreins: the cancer biomarker family. Cancer Lett. 2007;249:61-79.
13. Tanimoto H, Underwood LJ, Shigemasa K, Parmley TH, O'Brien TJ. Increased expression of protease m in ovarian tumors. Tumour Biol. 2001;22:11-8.
14. Hoffman BR, Katsaros D, Scorilas A, Diamandis P, Fracchioli S. Rigault de la Longrais IA, Colgan T, Puopolo M, Giardina G, Massobrio M, Diamandis EP. Immun of luorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br J Cancer. 2002;87:763-71.
15. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M. Clinical significance of human kallikrein gene 6 messenger rna expression in colorectal cancer. Clin Cancer Res. 2005;11:2889-93.
16. Santin AD, Diamandis EP, Bellone S, Soosaipillai A, Cane S, Palmieri M, Burnett A, Roman JJ, Pecorelli S. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Clin Cancer Res. 2005;11:3320-5.
17. Palmer HG, Sanchez-Carbayo M, Ordonez-Moran P, Larriba MJ, Cordon-Cardo C, Munoz A. Genetic signatures of differentiation induced by 1alpha, 25-dihydroxyvitamin d3 in human colon cancer cells. Cancer Res. 2003;63:7799-806.
18. Lin R, Nagai Y, Sladek R, Bastien Y, Ho J, Petrecca K, Sotiropoulou G, Diamandis EP, Hudson TJ, White JH. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol. 2002;16:1243-56.
19. Bayes A, Tsetsenis T, Ventura S, Vendrell J, Aviles FX, Sotiropoulou G. Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation. Biol Chem. 2004;385:517-24.
20. Pampalakis G, Prosnikli E, Agalioti T, Vlahou A, Zoumpourlis V, Sotiropoulou G. A tumor-protective role for human kallikreinrelated peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition. Cancer Res. 2009;69:3779-87.
21. Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P. Human kallikrein 6 (zyme/protease m/neurosin): a new serum biomarker of ovarian carcinoma. Clin Biochem. 2000;33:579-83.
22. Diamandis EP, Scorilas A, Fracchioli S, Van Gramberen M, De Bruijn H, Henrik A, Soosaipillai A, Grass L, Yousef GM, Stenman UH, Massobrio M, Van der Zee AG, Vergote I, Katsaros D. Human kallikrein 6 (hk6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J Clin Oncol. 2003;21:1035-43.
23. Nagahara H, Mimori K, Utsunomiya T, Barnard GF, Ohira M, Hirakawa K, Mori M. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin Cancer Res. 2005;11:6800-6.
24. Ni X, Zhang W, Huang KC, Wang Y, Ng SK, Mok SC, Berkowitz RS, Ng SW. Characterisation of human kallikrein 6/protease m expression in ovarian cancer. Br J Cancer. 2004;91:725-31.
25. Yousef GM, Borgono CA, Popalis C, Yacoub GM, Polymeris ME, Soosaipillai A, Diamandis EP. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers. Anticancer Res. 2004;24:43-51.
26. Kim JT, Song EY, Chung KS, Kang MA, Kim JW, Kim SJ, Yeom YI, Kim JH, Kim KH, Lee HG. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer. Cancer. 2011;117:2608-19.
27. Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP. Molecular characterization of zyme/protease m/neurosin (prss9), a hormonally regulated kallikrein-like serine protease. Genomics. 1999;62:251-9.
28. Luo LY, Soosaipillai A, Grass L, Diamandis EP. Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients. Tumour Biol. 2006;27:227-34.
29. Henkhaus RS, Roy UK, Cavallo-Medved D, Sloane BF, Gerner EW, Ignatenko NA. Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Neoplasia. 2008;10:140-8.
30. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994;1198:11-26.
31. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol. 1993;5:806-11.